Group 1: Asset Purchase Agreement - Aja Health and Wellness Inc. has signed an Asset Purchase Agreement to acquire assets from Canadian Travel and Doctors Clinics Inc. for a purchase price of CAD 150,000 [2] Group 2: Share Subscription Agreement - Aja has entered into a Share Subscription Agreement with GEM Global Yield LLC SCS, agreeing to subscribe for up to CAD 25 million of securities over three years [3] - The Subscription Agreement allows Aja to issue Draw Down Notices to request capital from GEM, subject to certain conditions [4] Group 3: Financial Obligations and Fees - Aja has agreed to pay a fee of CAD 500,000 to GEM Yield Bahamas Limited, which can be paid in various forms including cash or Common Shares [6] Group 4: Financial Reporting and Compliance - Aja is working to file its annual audited financial statements for the year ending December 31, 2024, and interim financial statements for the three months ended March 31, 2025, by September 15, 2025 [7][9] - The delay in filing is due to the need for a valuation related to a previous reverse takeover transaction [8]

LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the winners of the 2025 Catalyst Awards, an annual program recognizing healthcare organizations at the forefront of data-driven transformation. The Catalyst Awards were presented at the Health Catalyst Analy ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making false and misleading statements regarding its business and financial conditions [1][2]. Allegations - Nutex and its executives are accused of failing to disclose material facts about the company's business and finances [2]. - The lawsuit claims that Nutex benefited from arbitration results secured by HaloMD, which is alleged to have engaged in fraudulent schemes to defraud insurance companies [6]. - It is alleged that Nutex reported unsustainable revenues tied to this alleged fraud [6]. - The company is accused of overstating its remediation of internal control weaknesses over financial reporting [6]. - Nutex allegedly failed to properly account for stock-based compensation obligations, misclassifying them as equity instead of liabilities [6]. - The lawsuit highlights an increased risk of delayed SEC filings due to these accounting errors [6]. - Nutex is accused of overstating its business and financial prospects through misleading positive statements [6]. Key Events - On July 22, 2025, a report from Blue Orca Capital alleged that Nutex used HaloMD in fraudulent arbitration schemes, resulting in a stock price drop of $11.18 (10.1%), closing at $100.01 [6]. - On August 14, 2025, Nutex announced a delay in its Q2 2025 financial filings due to accounting issues related to stock-based compensation, leading to a further stock price decline of $18.22 (16.4%), closing at $92.91 on August 15 [6]. Class Period and Deadlines - The class period for the lawsuit is from August 8, 2024, to August 14, 2025 [6]. - The deadline to file a lead plaintiff motion is October 21, 2025 [6].

PHILADELPHIA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine is actively investigating a data breach at Healthcare Services Group, Inc. On August 27, 2025, Healthcare Services Group, Inc. (“HSGI”) announced that more than ten months earlier, on October 7, 2024, it had “learned of potential unauthorized access to certain HSGI computer systems.” Upon investigation, HSGI determined that “an unauthorized actor may have accessed and copied certain files on HSGI’s computer systems between September 27, ...

The Cooper Companies (COO) Q3 2025 Earnings Call August 27, 2025 05:00 PM ET Company ParticipantsKim Duncan - VP of IR & Risk ManagementAlbert White - President, CEO & DirectorBrian Andrews - EVP, CFO & TreasurerJonathan Block - Managing DirectorIssie Kirby - VP - Equity Research, Medical Technology & Life SciencesJoanne Wuensch. - Managing DirectorBradley Bowers - VP - Equity ResearchPatrick Wood - Managing DirectorConference Call ParticipantsLawrence Biegelsen - Senior Medical Device Equity Research Analy ...

Group 1 - Centene (NYSE: CNC) has experienced a significant decline, losing over 60% of its market cap in the past twelve months, leading to a low valuation [1] - The article emphasizes the importance of fundamental analysis in making informed investment decisions, highlighting the author's background in IT and experience in managing a family portfolio [1] - The author aims to provide accessible insights for investors of all experience levels, focusing on various sectors and uncovering promising investment opportunities [1] Group 2 - There is a potential for the author to initiate a long position in Centene (CNC) within the next 72 hours, indicating a possible bullish outlook [2] - The article expresses the author's personal opinions and does not involve any compensation from companies mentioned, ensuring an unbiased perspective [2] - Seeking Alpha clarifies that past performance does not guarantee future results and that the views expressed may not reflect the platform's overall stance [3]

Core Viewpoint - Nutex is facing significant legal and financial challenges due to allegations of fraudulent activities related to its partnership with HaloMD, which have led to a substantial decline in its stock price [2][3][4]. Group 1: Allegations and Legal Issues - The complaint against Nutex claims that the company and its executives violated federal securities laws by making false statements and failing to disclose critical information regarding their operations with HaloMD [2]. - Allegations include that Nutex engaged in a scheme to defraud insurance companies, resulting in unsustainable revenue from its dealings with HaloMD [2]. - The company is accused of overstating its ability to remediate internal control weaknesses, which affected its financial reporting and stock-based compensation calculations [2]. Group 2: Stock Price Impact - Following the release of a short report by Blue Orca Capital, Nutex's stock price dropped by $11.18 per share, or 10.05%, closing at $100.01 on July 22, 2025 [4]. - After Nutex announced a delay in filing its Form 10-Q due to accounting adjustments, its stock price fell further by $18.22 per share, or 16.39%, closing at $92.91 on August 15, 2025 [4]. Group 3: Company Response - Nutex publicly disagreed with the allegations made in the Blue Orca report and indicated that updates would be provided in its upcoming earnings release [4]. - The company has not effectively rebutted the allegations, which has contributed to the decline in investor confidence and stock value [4].

Key Takeaways CVS posted revenue growth across all segments in Q2 2025 and is restoring Aetna's target marginsElevance cut its 2025 EPS outlook to $30 as ACA and Medicaid challenges weigh on earnings.CVS boosts digital health with $20B investment and targets $500M in cost savings next year.The U.S. healthcare services market continues to climb steadily and is set to expand to $9.25 trillion in 2025 from $8.77 trillion in 2024 (as per Research and Markets). Growth is fueled by factors like telehealth and dig ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Centene Corporation ("Centene " or the "Company") (NYSE: CNC) investors of a class action representing investors that bought securities between December 12, 2024 through June 30, 2025, inclusive (the "Class Period"). Centene investors have until September 8, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesl ...